Salasani, Sedi -.

HRN: 25-17-69  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2024
CEFTRIAXONE 1G (VIAL)
06/02/2024
06/08/2024
IV DRIP
400mg
Q12
PCAP-C
Waiting Final Action 
06/02/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
06/02/2024
06/08/2024
PO
2mL
OD
PCAP-C
Waiting Final Action 
06/05/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/06/2024
06/12/2024
IVTT
80mg
Q8h
T/c GI Bleed, FOBT Positive
Waiting Final Action 
01/23/2025
CEFUROXIME 750MG (VIAL)
01/23/2025
01/30/2025
IV
300mg
Q8h
PCAP C
Waiting Final Action 
01/25/2025
CEFTRIAXONE 1G (VIAL)
01/25/2025
02/01/2025
IV
455mg
Q12H
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: